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Aims
To describe the cases of occupational asthma (OA) diagnosed at the Finnish Institute of Occupational Health (FIOH) during the period 1994-2004 in workers employed in professional cleaning work.
Methods
OA was diagnosed according to patient history, lung function examinations and specific challenge tests with measurements of the forced expiratory volume in 1 second and peak expiratory flow values.
Results
Our series comprised 20 patients, all female, with a mean age of 48.8 years (range 27-60 years). The mean duration of cleaning work before the onset of the respiratory symptoms was 14.3 years (range 1-36 years), and the mean duration of cleaning work before the FIOH examinations was 18.6 years (range 3-38 years). OA was triggered by chemicals in 9 cases (45%) and by moulds in 11 cases (55%). The chemicals were cleaning chemicals (wax-removing substances containing ethanolamines in five cases and a cleaning agent containing chloramine-T in one case) and chemicals used in the industrial processes at workplaces (three cases). Of the moulds, the most frequently associated with OA was Aspergillus fumigatus (nine cases).
Introduction
Cleaning is a huge business today and it is estimated that 3% of the workforce work as cleaners in Finland with a corresponding figure in the USA is 4% [1] . Professional cleaning includes diverse work tasks: cleaning offices, industrial plants, hospitals and homes. Professional cleaners are not only exposed to a large amount of chemical compounds in cleaning agents but also to organic compounds, such as animal dander, mites and microbes from damp environments, and to particles and chemicals emitted from building structures [1] . Adverse respiratory health effects associated with professional cleaning include asthma and lung function abnormalities and possibly chronic bronchitis [2] . Registry-based studies have reported an increased risk of asthma among professional cleaners [3] [4] [5] [6] , and several population-based studies have made the same observation [7] [8] [9] [10] [11] [12] [13] . In addition to epidemiological studies, case reports have described occupational asthma (OA) in relation to exposure to various cleaning agents, such as ethanolamines [14, 15] and chloramine-T [16, 17] .
To date, no analysis of large patient series from a clinic of occupational medicine has been published. In the present paper, we describe a series consisting of 20 professional cleaners in which the diagnosis of OA was confirmed with inhalation challenge test (ICT).
Methods
This study consists of the cases (a subject with OA with positive challenge test) diagnosed at the Finnish Institute of Occupational Health (FIOH) during the period 1994-2004. The patients were referred to FIOH by either physicians of local occupational health units or pulmonologists of local central hospitals from all over Finland. Investigations at FIOH included allergologic and lung function examinations with specific ICTs. The Ethics Committee of FIOH approved the study.
Skin-prick tests (SPT) for common environmental allergens (ALK-Abello A/S, Copenhagen, Denmark) as well as for work-related allergens were performed as reported previously [18] . Histamine hydrochloride (10 mg/ml) was used as the positive control. The environmental allergens were as follows: pollens of birch, alder, timothy hay, meadow foxtail, mugwort and dandelion; epithelia of horse, dog, cat and cow; dust mites (Dermatophagoides farinae and Dermatophagoides pteronyssinus) and moulds (Alternaria alternata and Cladosporium herbarum). The work-related allergens were as follows: ethanolamine [monoethanolamine (MEA), diethanolamine (DEA) and triethanolamine (TEA)], chloramine-T, formaldehyde, storage mites (Acarus siro, Lepidoglyphus destructor and Tyrophagus putrescentiae), latex, Ficus benjamina, metal salts (hexavalent and trivalent chromium, nickel and cobalt), isocyanates [hexamethylene diisocyanate (HDI), diphenylmethane diisocyanate (MDI) and toluene diisocyanate (TDI)] and moulds (Table 1) . A positive reaction was defined as a wheal diameter $3 mm in the absence of a reaction to the diluent and in the presence of a positive reaction to histamine hydrochloride.
Until 1996, the total IgE values were determined by the Pharmacia CAP system IgE RIA (Kabi Pharmacia Diagnostics, Uppsala, Sweden). Since then, these values have been measured using the Uni-CAP system (Pharmacia & Upjohn, Uppsala, Sweden).
Atopy was defined as either positive results to common environmental allergens (one or more allergens) in SPTs or positive atopic history (earlier infantile eczema, atopic dermatitis, hay fever or other allergic rhinitis).
Flow-volume spirometry was performed with a pneumotachograph spirometer connected to a microcomputer (Medicro MR909; Medikro, Kuopio, Finland), using Viljanen's reference values [19] . Three spirograms were taken at each measurement. Spirometry was performed in accordance with the recommendations of European Respiratory Society, and forced vital capacity (FVC), forced expiratory volume in 1 second (FEV 1 ) and the FEV 1 /FVC ratio (FEV%) were measured. Spirometry values were graded as follows: normal (FEV 1 . 80%, FVC . 81% and FEV% . 87% of predicted value); mild deterioration (FEV 1 65-80% and/or FVC 65-81% and/ or FEV% 78-87% of predicted value); moderate deterioration (FEV 1 45-64% and/or FVC 45-64% and/or FEV% 62-77% of predicted value) and strong deterioration (FEV 1 , 45% and/or FVC , 45% and/or FEV% , 62% of predicted value). A histamine challenge test was performed according to Sovijärvi's method [20] ; the provocative dose of 1.6% histamine diphosphate causing a 15% reduction in FEV 1 (provocative dose, PD 15 ) was measured. The bronchial hyperresponsiveness was graded as strong with PD 15 , 0.10 mg, moderate with PD 15 0.11-0.40 mg and mild with PD 15 0.41-1.6 mg. Peak expiratory flow (PEF) monitoring during work days and days off was carried out according to Burge's method [21] . During the monitoring, inhaled steroids and shortacting bronchodilators (when needed) were allowed. Combination treatments were changed into inhaled steroids alone, and long-acting bronchodilators were discontinued.
OA was diagnosed according to European guidelines [22] . ICTs were performed in a 6 m 3 test chamber in all cases except for those of nickel sulphate and moulds, which were carried out using an inspiratory synchronized dosimetric device. Additionally, one ICT was conducted as a workplace challenge. The challenge test substance was the most likely allergen, based on a careful clinical analysis of the patient's exposure. The challenge test procedure varied according to the test substance as shown below. All the patients went through a placebo test with a nonallergenic substance. All asthma medication was discontinued during the ICTs. If asthma was unstable without any treatment, inhaled steroids were allowed. In that case, the whole dosage per day was taken in the evening. Waxremoving detergents containing ethanolamines: The patient's own wax-removing detergent (WRD) (5-100 ml) was mixed with 1-5 l of 40°C water in the test chamber at the beginning of the ICT, and the mixture was left to evaporate in the chamber over the duration of the test (from 30 to 45 min). One ICT was carried out as a workplace challenge using wax-and TEA-containing WRD according to the normal working procedure. In the placebo tests, paint with no sensitizers but with slight odour (a polyol component of a polyurethane pain) was used in two cases, a control solution (containing 5 mg/ml sodium chloride, 4 mg/ml phenol and 2.75 mg/ml sodium bicarbonate in sterile water) was used in two cases and a lactose powder in one case. Chloramine-T: The patient's own cleaning agent containing chloramine-T (10 ml) was mixed with 40°C water at the beginning of the ICTand left to evaporate for 30 min. The placebo test was done with the control solution described above. HDI: The patient brushed 5 ml of an HDI-containing hardener used at the factory where she was working as a cleaner onto a disc (15 min). MDI: A solution of 3.1 mg of MDI in 1.5 ml toluene was sprayed into the test chamber with compressed air at the beginning of the ICT (15 min). In HDI and MDI ICTs, the placebo tests were done with a non-sensitizing polyol component of a polyurethane paint. Nickel sulphate: A standard solution of 10 mg/ml of nickel sulphate (NiSO 4 ) in water was inhaled via an inspiratory synchronized dosimeter with 12 inhalations over 30 min. Lactose powder was used in the placebo test. Moulds: Commercial allergen extracts of Aspergillus fumigatus, Acremonium kiliense and C. herbarum were used (ALK-Abelló). The mould species were primarily selected from among the species found in the microbial workplace samples. Allergen extracts diluted with ALK solvent (ALK-Abelló ) were inhaled by an inspiratory synchronized dosimetric device (Spira Electro 2) with the following settings: driving pressure 0.2 kPa (two bars), inhalation time 0.8 s, starting volume 50 ml, inspiratory flow 0.5 6 0.1 l/s and amount of allergen mixture 0.8-1.0 ml. The starting allergen dilution was 1:10 000-1:1000 weight/volume (wt/vol) depending on the severity of the patient's symptoms and the strength of sensitization. The allergen dose was increased 5-to 10-fold every 15 min if the patient had not reacted to the earlier dose, until a dilution of 1:5 wt/vol was achieved. The placebo tests for moulds were done with the pure diluent.
Patients were monitored for 24 h after each ICT. A portable pocketsize spirometer (One Flow; STI MEDI-CAL, Saint-Romans, France) recorded the lung function measurements (FEV 1 , PEF), and a drop of 20% of PEF or FEV 1 was regarded as significant. Clinical symptoms and lung auscultation findings were also recorded. An asthmatic reaction was defined as follows: an immediate reaction causing a drop $20% in FEV 1 or PEF values (compared with the baseline values) during the first post-challenge hour; a delayed reaction causing a similar FEV 1 or PEF drop after the first post-challenge hour and a dual reaction as a combination of the above mentioned. If the patient experienced either immediate asthmatic symptoms and/or a significant drop in lung function, parameters (FEV 1 , PEF) were recorded and ICT was interrupted.
If occupational rhinitis or laryngitis was clinically suspected, the otorhinolaryngological status was observed by an otorhinolaryngologist both before and immediately after the challenge test.
We compared the proportional data with the chisquare test or with Fisher's exact test and applied the Mann-Whitney U-or Student's t-tests in comparisons of continuous variables. Differences at the 5% level were considered statistically significant. Data were analysed using the SPSS statistical software system, version 10.05 (SPSS, Inc., Chicago, IL, USA).
Results
All the study patients were professional cleaners. They were exposed to cleaning chemicals and other chemicals used in their work processes; in addition, 15 were exposed to moulds detected in the work environment. The mean duration of cleaning work before the FIOH examinations was 18.6 years (range 3-38 years), and the mean duration of such work before the onset of the respiratory symptoms was 14.3 years (range 1-36 years). Three of the patients had discontinued their work before the FIOH examinations.
The mean age of the patients was 48.8 years (range 27-60 years), and all 20 were female ( Table 2) . Three (15%) were current smokers, 5 (25%) were ex-smokers and 12 (65%) had never smoked. Dyspnoea was the most frequently reported work-related respiratory symptom (reported in all patients), followed by cough (all but three patients). Wheezing was reported by 60% of the patients. Nine (45%) patients had also experienced nasal, 10 (50%) laryngeal and 7 (35%) ocular symptoms connected to work.
Before the FIOH investigations, bronchial asthma was diagnosed in 17 (85%) patients and 3 patients had respiratory symptoms related to cleaning work without asthma diagnosis. Regular asthma medication had been started by 18 (90%) patients, and a bronchodilating agent on demand had been given to 1 (5%) additional patient. Before the FIOH examinations, eight (40%) patients had positive SPT reactions to common environmental allergens, and during the FIOH examinations, seven (35%) patients; in total, 10 (50%) different patients showed positive SPT reactions to common environmental allergens. At FIOH, positive SPT reactions were shown to the following work-related allergens: moulds (three cases), storage mites (two cases) and latex (one case). Furthermore, SPTs to ethanolamines were performed in nine (45%) and to chloramine-T in three (15%) patients. None of the SPTs to ethanolamines were positive, but there was one positive reaction to chloramine-T, the positive reaction being detected in the patient who was diagnosed with OA to chloramine-T. Five (25%) patients had an elevated (.114 kU/l) total IgE concentration (range 133-886).
At FIOH, spirometry was normal or showed only mild obstruction in most patients (Table 3) . Likewise, most of the patients tested showed none or only mild bronchial hyperresponsiveness in the histamine provocation test. PEF monitoring during work days and days off was performed at FIOH in seven (35%) patients. They were compatible with OA in three cases; in one, a proper evaluation was not possible, and in three cases, serial PEF measurements did not fit OA. In the rest of the patients, PEF monitoring during work days and days could not be performed because they had stopped their work as cleaners either permanently or currently (they were on sick leave).
All 20 patients underwent an active challenge test. OA was triggered by chemicals in 9 cases (45%) and by moulds in 11 cases (55%). The chemicals were WRDs containing ethanolamines (five cases), a cleaning agent containing chloramine-T (one case), HDI (one case), MDI (one case) and nickel sulphate (one case). The moulds were A. fumigatus (nine cases), A. kiliense (one case) and C. herbarum (one case). The mode of the asthmatic FEV 1 /PEF reaction was delayed in 13 (65%), immediate in 5 (25%) and dual in 2 (10%) patients. There were no statistical differences related to the occurrence of the mode of the asthmatic reaction (delayed versus immediate or dual reaction) between patients with serum IgE positivity, SPT reaction positivity to common environmental allergens, positive family history of asthma or positive history of atopy (data not shown). Furthermore, the duration of exposure or the duration of exposure before the respiratory symptoms did not differ significantly between these groups (data not shown). During the challenge tests, otorhinolaryngological status was observed in five (25%) patients, but no diagnosis of occupational upper respiratory tract disease was made. In all patients, the control challenge test was negative.
After the diagnosis of OA, all patients either continued or started regular asthma medication. At FIOH, the assessment of work ability was based on the description of work tasks, lung function measurements and PEF surveillances (both before and during the examinations). Before the FIOH examinations, one patient had already retired. After the FIOH examinations, all patients except one (a 59-year-old cleaner with OA induced by HDI) were assumed to be able to continue in their current work if the exposure to the causative agent of their OA was stopped (Table 4) .
Discussion
The present study described clinically examined patients with OA diagnosed with positive challenge tests on cleaners. The diagnosis of OA was based on a history of exposure, respiratory symptoms and clinical examinations, including positive challenge tests. During the 11 year period of our study, 20 OA cases were diagnosed at FIOH, which gives an occurrence of OA 1.8/year. It is estimated that there are 56 000 professional cleaners in Finland, which has a population of 5.3 million habitants. If we apply this estimate for the number of cleaners in [23] . When using this figure, cleaners' asthma contributed 2 of 350 (0.006).
In the present series, OA was attributable to cleaning chemicals, including WRD and chloramine-T. The five cases of OA due to WRDs were either to MEA or TEA. In the respective cases, the ICTs were carried out with the patients' own WRD, except in one case, where the ICT was performed both with the patient's WRD and with the TEA that was present in the WRD; in the respective case, the ICT was positive only with the pure TEA. Ethanolamines were considered the most likely cause of the reaction also in the remaining four cases. Ethanolamines have also previously been reported as causing OA [14, 15] , but only one of the earlier reported cases has been in a cleaner [14] . As far as we know, IgE-mediated allergy to ethanolamines has not been reported in association with OA. We did not observe such an allergy in the present series, indicating that the pathophysiology of OA due to ethanolamines probably involves other immunological mechanisms.
Unlike ethanolamines, chloramine-T has been reported to cause OA in association with IgE-mediated allergy [16, 17] . Also our one case of OA triggered by chloramine-T had positive SPT to chloramine-T.
Our patients were exposed not only to cleaning chemicals but also to other chemicals used in the work processes at their workplaces. The two cases of OA due to diisocyanates were diagnosed in industrial cleaners who were exposed to chemicals of nearby work processes (HDI-containing hardener of car paint and MDI-containing insulation foam). Diisocyanates are well-known respiratory sensitizers [24] and should be considered possible causes of asthma in cleaning work performed in workplaces where paints, glues, foams or varnishes are used. Additionally, one case of OA due to nickel sulphate was observed in an industrial cleaner. Nickel sulphate is known as being capable of inducing OA [25] .
Our clinical series presents mould as a new cause of OA in cleaners. An increased risk of asthma in the presence of visible indoor mould has been reported in epidemiological studies conducted in adults [26, 27] . Moreover, recent patient series support the evidence of an association between exposure to damp and mouldy workplaces and both new-onset adult asthma [28] and rhinitis [29] . Since 1995, indoor moulds from waterdamaged buildings have caused an increasing number of OA cases and have become the most significant causative agents in Finland [23] . The mechanisms behind respiratory symptoms related to mouldy environments are poorly understood. IgE mediation seems to be a rare mechanism, whereas other mechanisms are unknown [28] .
Besides work-related lower respiratory symptoms, 75% of our patients reported nasal or laryngeal symptoms. However, no diagnosis of occupational upper respiratory tract disease was made based on the otorhinolaryngological findings observed during the challenge tests. To our best knowledge, no cases of challenge test positive occupational rhinitis or laryngitis associated with cleaning agents have been published in the literature.
As the ICTs are burdensome for patients, it was not practical to test all possible workplace substances. The ICTs were planned so that the most probable allergens were included, based on a careful clinical analysis of the patient's exposure. Patients indicated when they first suffered work-related respiratory symptoms and to what substances they associated them. The mean duration of such work before the onset of the respiratory symptoms was long (14.3 years). It is possible that the exposure could have varied during different times and it is not possible to state that the patients always used the same substances at work over their whole employment. Thirty-five percent of our patients did not have bronchial hyperresponsiveness measured by a histamine challenge test. Although patients with OA usually demonstrate evidence of bronchial hyperresponsiveness, it is not mandatory for a diagnosis of OA. Moreover, there is no doubt that all of our patients had OA because they all had a positive reaction in the SIC test. The reasons for the lack of bronchial hyperresponsiveness in the present series include absence from work and subsequent cessation of work exposure as well as the use of asthma medication.
